0001209191-22-051014.txt : 20220922
0001209191-22-051014.hdr.sgml : 20220922
20220922161452
ACCESSION NUMBER: 0001209191-22-051014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220920
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RICHMAN ERIC I
CENTRAL INDEX KEY: 0001313876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 221259378
MAIL ADDRESS:
STREET 1: LEV PHARMACEUTICALS INC
STREET 2: 122 EAST 42ND STREET STE 206
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-20
0
0001819411
Gain Therapeutics, Inc.
GANX
0001313876
RICHMAN ERIC I
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
1
0
0
0
Employee Stock Option (right to buy)
3.50
2022-09-20
4
A
0
329400
0.00
A
2032-09-20
Common Stock
329400
329400
D
Restricted Stock Units
2022-09-20
4
A
0
54900
0.00
A
Common Stock
54900
54900
D
The shares underlying the option shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The RSUs shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date.
/s/ Jason Minio, Attorney-in-Fact
2022-09-22